|
1
|
Gu Y, Dee CM and Shen J: Interaction of
free radicals, matrix metalloproteinases and caveolin-1 impacts
blood-brain barrier permeability. Front Biosci (Schol Ed).
3:1216–1231. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion - from mechanism to translation. Nat Med. 17:1391–1401.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gu Y, Chen J and Shen J: Herbal medicines
for ischemic stroke: Combating inflammation as therapeutic targets.
J Neuroimmune Pharmacol. 9:313–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Obermeier B, Daneman R and Ransohoff RM:
Development, maintenance and disruption of the blood-brain barrier.
Nat Med. 19:1584–1596. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han JZ, Sun J, Zhu QG, Liu JY, Hu JH and
Chen F: A modified LC-MS/MS method for determination of
tetramethylpyrazine in microdialysis samples and calibration of
home-made linear probes. Biomed Chromatogr. 26:1276–1281. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chun-sheng L, Hsiao-meng Y, Yun-hsiang H,
Chun P and Chi-fen S: Radix Salviae Miltiorrhizae and Rhizoma
Ligustici Wallichii in coronary heart disease. Chin Med J (Engl).
4:43–46. 1978.PubMed/NCBI
|
|
7
|
Zhu XL, Xiong LZ, Wang Q, Liu ZG, Ma X,
Zhu ZH, Hu S, Gong G and Chen SY: Therapeutic time window and
mechanism of tetramethylpyrazine on transient focal cerebral
ischemia/reperfusion injury in rats. Neurosci Lett. 449:24–27.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kao TK, Ou YC, Kuo JS, Chen WY, Liao SL,
Wu CW, Chen CJ, Ling NN, Zhang YH and Peng WH: Neuroprotection by
tetramethylpyrazine against ischemic brain injury in rats.
Neurochem Int. 48:166–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao X, Liu Y, Qi C, Qiu F, Chen X, Zhang
J and Yang P: Neuroprotection and enhanced neurogenesis by
tetramethylpyrazine in adult rat brain after focal ischemia. Neurol
Res. 32:547–555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liao SL, Kao TK, Chen WY, Lin YS, Chen SY,
Raung SL, Wu CW, Lu HC and Chen CJ: Tetramethylpyrazine reduces
ischemic brain injury in rats. Neurosci Lett. 372:40–45. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kao TK, Chang CY, Ou YC, Chen WY, Kuan YH,
Pan HC, Liao SL, Li GZ and Chen CJ: Tetramethylpyrazine reduces
cellular inflammatory response following permanent focal cerebral
ischemia in rats. Exp Neurol. 247:188–201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shih YH, Wu SL, Chiou WF, Ku HH, Ko TL and
Fu YS: Protective effects of tetramethylpyrazine on kainate-induced
excitotoxicity in hippocampal culture. Neuroreport. 13:515–519.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li SY, Jia YH, Sun WG, Tang Y, An GS, Ni
JH and Jia HT: Stabilization of mitochondrial function by
tetramethylpyrazine protects against kainate-induced oxidative
lesions in the rat hippocampus. Free Radic Biol Med. 48:597–608.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu C, Zhang J, Shi X, Miao S, Bi L, Zhang
S, Yang Q, Zhou X, Zhang M, Xie Y, et al: Neuroprotective effects
of tetramethylpyrazine against dopaminergic neuron injury in a rat
model of Parkinson's disease induced by MPTP. Int J Biol Sci.
10:350–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leng YF, Gao XM, Wang SX and Xing YH:
Effects of tetramethylpyrazine on neuronal apoptosis in the
superficial dorsal horn in a rat model of neuropathic pain. Am J
Chin Med. 40:1229–1239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan LH, Wang KZ, Cheng B, Wang CS and Dang
XQ: Anti-apoptotic and neuroprotective effects of
Tetramethylpyrazine following spinal cord ischemia in rabbits. BMC
Neurosci. 7:482006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng L, Ke N, Cheng F, Guo Y, Li S, Li Q
and Li Y: The protective mechanism of ligustrazine against renal
ischemia/reperfusion injury. J Surg Res. 166:298–305. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang Y, Hsiao G, Chen SH, Chen YC, Lin
JH, Lin KH, Chou DS and Sheu JR: Tetramethylpyrazine suppresses
HIF-1alpha, TNF-alpha, and activated caspase-3 expression in middle
cerebral artery occlusion-induced brain ischemia in rats. Acta
Pharmacol Sin. 28:327–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li XY, He JL, Liu HT, Li WM and Yu C:
Tetramethylpyrazine suppresses interleukin-8 expression in
LPS-stimulated human umbilical vein endothelial cell by blocking
ERK, p38 and nulear factor-kappaB signaling pathways. J
Ethnopharmacol. 125:83–89. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu Y, Zheng G, Xu M, et al: Caveolin-1
regulates nitric oxide-mediated matrix metalloproteinases activity
and blood-brain barrier permeability in focal cerebral ischemia and
reperfusion injury. J Neurochem. 120:147–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu F, Kamada H, Niizuma K, Endo H and Chan
PH: Induction of mmp-9 expression and endothelial injury by
oxidative stress after spinal cord injury. J Neurotrauma.
25:184–195. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Candelario-Jalil E, Thompson J, Taheri S,
Grossetete M, Adair JC, Edmonds E, Prestopnik J, Wills J and
Rosenberg GA: Matrix metalloproteinases are associated with
increased blood-brain barrier opening in vascular cognitive
impairment. Stroke. 42:1345–1350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vorbrodt AW and Dobrogowska DH: Molecular
anatomy of intercellular junctions in brain endothelial and
epithelial barriers: Electron microscopist's view. Brain Res Brain
Res Rev. 42:221–242. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sandoval KE and Witt KA: Blood-brain
barrier tight junction permeability and ischemic stroke. Neurobiol
Dis. 32:200–219. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krizbai IA and Deli MA: Signalling
pathways regulating the tight junction permeability in the
blood-brain barrier. Cell Mol Biol (Noisy-le-grand). 49:23–31.
2003.PubMed/NCBI
|
